{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:11:01Z","timestamp":1778904661712,"version":"3.51.4"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7131-26","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:10:49Z","timestamp":1778883049000},"source":"Crossref","is-referenced-by-count":0,"title":["A Delayed Progression of Porphyria-Associated Kidney Disease After Hemin Therapy in a Patient with Acute Intermittent Porphyria: A Case Report"],"prefix":"10.2169","author":[{"given":"Takuya","family":"Ishimura","sequence":"first","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken JC","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"},{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arisa","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumika","family":"Shikano","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Hanafusa","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Immunology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Handa","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"},{"name":"Department of Nephrology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngna","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"},{"name":"Division of Nephrology and Dialysis, Ozawa Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Muso","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition, Faculty of Contemporary Home Economics, Kyoto Kacho University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"},{"name":"Center for Preventive Medicine, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dickey AK, Leaf RK, Balwani M. Update on the Porphyrias. Annu Rev Med 75: 321-335, 2024.","DOI":"10.1146\/annurev-med-042921-123602"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Bissell DM. Porphyria. The New England journal of medicine 377 (9): 862-872, 2017.","DOI":"10.1056\/NEJMra1608634"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Song C, Liu Y. A high urinary urobilinogen\/serum total bilirubin ratio indicates acute hepatic porphyria in patients with abdominal pain. Scientific Reports 13 (1): 2023.","DOI":"10.1038\/s41598-023-48824-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Szlendak U, Bykowska K, Lipniacka A. Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria. Adv Clin Exp Med 25 (2): 361-368, 2016.","DOI":"10.17219\/acem\/58955"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Puy H, Deybach JC, Lamoril J, et al. Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. Am J Hum Genet 60 (6): 1373-1383, 1997.","DOI":"10.1086\/515455"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fraunberg M, Pischik E, Udd L, Kauppinen R. Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria. Medicine (Baltimore) 84 (1): 35-47, 2005.","DOI":"10.1097\/01.md.0000152455.38510.af"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. C. Andersson YFAW. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study. Scandinavian journal of clinical and laboratory investigation 60 (7): 643-648, 2000.","DOI":"10.1080\/003655100300054891"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ma L, Tian Y, Peng C, Zhang Y, Zhang S. Recent advances in the epidemiology and genetics of acute intermittent porphyria. Intractable &amp; Rare Diseases Research 9 (4): 196-204, 2020.","DOI":"10.5582\/irdr.2020.03082"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dawit S, Bhatt SK, Das DM, et al. Nonconvulsive status epilepticus secondary to acute porphyria crisis. Epilepsy Behav Case Rep 11: 43-46, 2019.","DOI":"10.1016\/j.ebcr.2018.11.002"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Jaramillo-Calle DA, Solano JM, Rabinstein AA, Bonkovsky HL. Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction. Molecular Genetics and Metabolism 128 (3): 242-253, 2019.","DOI":"10.1016\/j.ymgme.2019.10.011"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Pallet N, Karras A, Thervet E, Gouya L, Karim Z, Puy H. Porphyria and kidney diseases. Clinical Kidney Journal 11 (2): 191-197, 2018.","DOI":"10.1093\/ckj\/sfx146"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Church SE, McColl KE, Moore MR, Youngs GR. Hypertension and renal impairment as complications of acute porphyria. Nephrol Dial Transplant 7 (10): 986-990, 1992.","DOI":"10.1093\/ndt\/7.10.986"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Pallet N. High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria. Kidney international 88 (2): 386-395, 2015.","DOI":"10.1038\/ki.2015.97"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Ricci A, Guida CC, Manzini P, Cuoghi C, Ventura P. Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications. Diagnostics 11 (12): 2324, 2021.","DOI":"10.3390\/diagnostics11122324"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Middelburg TA, de Bruijn HS, Tettero L, et al. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: Complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall. Journal of Photochemistry and Photobiology B: Biology 126: 26-32, 2013.","DOI":"10.1016\/j.jphotobiol.2013.06.014"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Balwani M, Sardh E, Ventura P, et al. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria. New England Journal of Medicine 382 (24): 2289-2301, 2020.","DOI":"10.1056\/NEJMoa1913147"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sardh E, Balwani M, Rees DC, et al. Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1\/2, 48-month open-label extension study. Orphanet Journal of Rare Diseases 19 (1): 2024.","DOI":"10.1186\/s13023-024-03284-w"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7131-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:27:24Z","timestamp":1778902044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7131-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":17,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7131-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7131-26"}}